Anti-cancer therapy success

被引：0
|
作者：
Wong, JF [1 ]
机构：
[1] SciFin, Los Angeles, CA USA
来源：
GENETIC ENGINEERING NEWS | 2005年 / 25卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：48 / 49
页数：2
相关论文
共 50 条
  • [21] The cancer stem cell microenvironment and anti-cancer therapy
    Ghotra, Veerander P. S.
    Puigvert, Jordi C.
    Danen, Erik H. J.
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2009, 85 (11) : 955 - 962
  • [22] Roles of nucleolin Focus on cancer and anti-cancer therapy
    Chen, Zhuo
    Xu, XinHua
    SAUDI MEDICAL JOURNAL, 2016, 37 (12) : 1312 - 1318
  • [23] Cancer stem cell: target for anti-cancer therapy
    Tang, Carol
    Ang, Beng T.
    Pervaiz, Shazib
    FASEB JOURNAL, 2007, 21 (14): : 3777 - 3785
  • [24] Are polyphenol antioxidants at the root of medicinal plant anti-cancer success?
    Oyenihi, A. B.
    Smith, C.
    JOURNAL OF ETHNOPHARMACOLOGY, 2019, 229 : 54 - 72
  • [25] Achieving clinical success with BET inhibitors as anti-cancer agents
    Shorstova, Tatiana
    Foulkes, William D.
    Witcher, Michael
    BRITISH JOURNAL OF CANCER, 2021, 124 (09) : 1478 - 1490
  • [26] VASCULAR EFFECTS OF ANTI-CANCER CISPLATIN THERAPY
    Cameron, Alan C.
    Hall, M.
    Rios, F.
    Waterston, A.
    White, J.
    Touyz, R. M.
    Lang, N. N.
    JOURNAL OF HYPERTENSION, 2018, 36 : E99 - E99
  • [27] Plant Virus Nanoparticles for Anti-cancer Therapy
    Venkataraman, Srividhya
    Apka, Paul
    Shoeb, Erum
    Badar, Uzma
    Hefferon, Kathleen
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2021, 9
  • [28] PET in anti-cancer drug development and therapy
    Kumar, Rakesh
    Lal, Neena
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2007, 2 (03) : 259 - 263
  • [29] Improved prospects for anti-cancer gene therapy
    Senior, K
    DRUG DISCOVERY TODAY, 2000, 5 (12) : 535 - 536
  • [30] Aurora kinase inhibitors as anti-cancer therapy
    Lok, Warren
    Klein, Rhonda Q.
    Saif, Muhammad Wasif
    ANTI-CANCER DRUGS, 2010, 21 (04) : 339 - 350
12345